The US government wants to speed gene-editing therapies to patients
The National Institutes of Health wants to help researchers cure inherited diseases using genome-editing technology.
New funding: The US biomedical research agency says it is dedicating $190 million over the next six years to researchers conducting gene-editing experiments, such as those with the powerful CRISPR technique.
The background: As the US moves closer to using CRISPR in humans, NIH is making special funds available as a way to “dramatically accelerate the translation of these technologies to the clinic for treatment of as many genetic diseases as possible,” says director Francis Collins.
No designer babies: NIH is only accepting proposals for studies that involve making edits to human somatic cells, the nonreproductive cells of the body. By law, the agency is forbidden from funding research that involves modifying embryos, which would result in edited DNA being passed down to the next generation.
Deep Dive
Biotechnology and health
Scientists are finding signals of long covid in blood. They could lead to new treatments.
Faults in a certain part of the immune system might be at the root of some long covid cases, new research suggests.
This baby with a head camera helped teach an AI how kids learn language
A neural network trained on the experiences of a single young child managed to learn one of the core components of language: how to match words to the objects they represent.
The next generation of mRNA vaccines is on its way
Adding a photocopier gene to mRNA vaccines could make them last longer and curb side effects.
Ready, set, grow: These are the biotech plants you can buy now
For $73, I bought genetically modified tomato seeds and a glowing petunia.
Stay connected
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.